Payment overview · 2025
General Payments
$81.33
4 reported records · 3 companies
Healthcare provider profile · identity verified
Dean Lance Ross, MD
Allopathic & Osteopathic Physicians|Family Medicine · OKLAHOMA CITY, OK · NPI 1952347361
Verified facts
What the public records show
CMS Open Payments records show Dean Lance Ross, MD received $81.33 in general payments during 2025 across 4 reported records.
Abbott Laboratories accounted for 48.1% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 4 associated products.
ABBVIE INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported LINZESS as an associated drug or biological on 87954 records involving 21815 distinct recipient NPIs. Public Medicare Part D data also shows 80 claims for Linzess by this doctor in 2024.
ABBVIE INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported SYNTHROID as an associated drug or biological on 10655 records involving 4881 distinct recipient NPIs. Public Medicare Part D data also shows 40 claims for Synthroid by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Abbott Laboratories | Unresolved — no canonical attribution shown | $39.12 | 48.1% | 2 | 2025 |
| Bausch Health US, LLC | Unresolved — no canonical attribution shown | $24.53 | 30.2% | 1 | 2025 |
| ABBVIE INC. | Unresolved — no canonical attribution shown | $17.68 | 21.7% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $81.33 | 4 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| FREESTYLE LIBRE 3 Normalized: freestyle libre 3 |
Device | Abbott Laboratories | $39.12 | 2 | 2025 |
Source payment records
|
|||||
| WELLBUTRIN Normalized: wellbutrin |
Drug | Bausch Health US, LLC | $24.53 | 1 | 2025 |
Source payment records
|
|||||
| QULIPTA Normalized: qulipta |
Drug | ABBVIE INC. | $17.68 | 1 | 2025 |
Source payment records
|
|||||
| UBRELVY Normalized: ubrelvy |
Drug | ABBVIE INC. | $17.68 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| ABBVIE INC. Exact reporting entity; no affiliate inference |
2025 | LINZESS open payments reported associated product |
CMS Open Payments — General Payments 87954 supporting records · 21815 recipient NPIs · example record 1201352608 |
Linzess · 2024 Exact normalized brand match · 1 Part D row |
80 | 14 |
| ABBVIE INC. Exact reporting entity; no affiliate inference |
2025 | SYNTHROID open payments reported associated product |
CMS Open Payments — General Payments 10655 supporting records · 4881 recipient NPIs · example record 1201352636 |
Synthroid · 2024 Exact normalized brand match · 1 Part D row |
40 | suppressed by CMS |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 760 | 204 |
| Levothyroxine Sodium | Levothyroxine Sodium | 691 | 178 |
| Gabapentin | Gabapentin | 636 | 132 |
| Amlodipine Besylate | Amlodipine Besylate | 542 | 148 |
| Montelukast Sodium | Montelukast Sodium | 431 | 108 |
| Lisinopril | Lisinopril | 427 | 117 |
| Losartan Potassium | Losartan Potassium | 354 | 94 |
| Omeprazole | Omeprazole | 339 | 84 |
| Meloxicam | Meloxicam | 325 | 82 |
| Alprazolam | Alprazolam | 314 | 39 |
| Duloxetine Hcl | Duloxetine Hcl | 310 | 63 |
| Zolpidem Tartrate | Zolpidem Tartrate | 308 | 38 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 306 | 83 |
| Hydrochlorothiazide | Hydrochlorothiazide | 303 | 82 |
| Pantoprazole Sodium | Pantoprazole Sodium | 297 | 88 |
| Fluticasone Propionate | Fluticasone Propionate | 255 | 79 |
| Metoprolol Succinate | Metoprolol Succinate | 255 | 66 |
| Metformin Hcl | Metformin Hcl | 230 | 67 |
| Tamsulosin Hcl | Tamsulosin Hcl | 227 | 62 |
| Tizanidine Hcl | Tizanidine Hcl | 226 | 82 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 214 | 57 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 212 | 62 |
| Ezetimibe | Ezetimibe | 195 | 45 |
| Eliquis | Apixaban | 192 | 36 |
| Bupropion Xl | Bupropion Hcl | 190 | 54 |
| Pregabalin | Pregabalin | 185 | 39 |
| Trazodone Hcl | Trazodone Hcl | 183 | 45 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 181 | 35 |
| Simvastatin | Simvastatin | 179 | 46 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 168 | 47 |
| Escitalopram Oxalate | Escitalopram Oxalate | 157 | 35 |
| Furosemide | Furosemide | 155 | 52 |
| Metoprolol Tartrate | Metoprolol Tartrate | 155 | 39 |
| Prednisone | Prednisone | 151 | 97 |
| Allopurinol | Allopurinol | 149 | 43 |
| Ozempic | Semaglutide | 141 | 29 |
| Azithromycin | Azithromycin | 139 | 103 |
| Metformin Hcl Er | Metformin Hcl | 138 | 48 |
| Potassium Chloride | Potassium Chloride | 138 | 45 |
| Mounjaro | Tirzepatide | 131 | 18 |
| Pioglitazone Hcl | Pioglitazone Hcl | 131 | 31 |
| Solifenacin Succinate | Solifenacin Succinate | 129 | 25 |
| Sertraline Hcl | Sertraline Hcl | 128 | 27 |
| Baclofen | Baclofen | 120 | 23 |
| Carvedilol | Carvedilol | 117 | 34 |
| Celecoxib | Celecoxib | 111 | 26 |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 109 | 85 |
| Methylprednisolone | Methylprednisolone | 103 | 88 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 97 | 26 |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 96 | 32 |
| Synjardy Xr | Empagliflozin/Metformin Hcl | 91 | 13 |
| Jardiance | Empagliflozin | 90 | 20 |
| Pravastatin Sodium | Pravastatin Sodium | 89 | 27 |
| Estradiol | Estradiol | 88 | 26 |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 88 | 22 |
| Lorazepam | Lorazepam | 86 | 11 |
| Eszopiclone | Eszopiclone | 84 | 19 |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 83 | 11 |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 81 | 59 |
| Tramadol Hcl | Tramadol Hcl | 81 | 13 |
| Clopidogrel | Clopidogrel Bisulfate | 80 | 22 |
| Linzess | Linaclotide | 80 | 14 |
| Clonazepam | Clonazepam | 78 | 15 |
| Diazepam | Diazepam | 76 | 14 |
| Paroxetine Hcl | Paroxetine Hcl | 76 | 21 |
| Citalopram Hbr | Citalopram Hydrobromide | 71 | 17 |
| Donepezil Hcl | Donepezil Hcl | 69 | 17 |
| Spironolactone | Spironolactone | 69 | 15 |
| Trulicity | Dulaglutide | 69 | 12 |
| Dutasteride | Dutasteride | 68 | 19 |
| Myrbetriq | Mirabegron | 68 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 68 | 23 |
| Famotidine | Famotidine | 67 | 22 |
| Acarbose | Acarbose | 64 | 18 |
| Carisoprodol | Carisoprodol | 63 | suppressed |
| Ibuprofen | Ibuprofen | 63 | 20 |
| Lovastatin | Lovastatin | 62 | 18 |
| Ondansetron Odt | Ondansetron | 61 | 24 |
| Dextroamphetamine-Amphetamine | Dextroamphetamine/Amphetamine | 59 | suppressed |
| Promethazine Hcl | Promethazine Hcl | 58 | 23 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 57 | 28 |
| Azelastine Hcl | Azelastine Hcl | 56 | 17 |
| Atenolol | Atenolol | 54 | 15 |
| Clonidine Hcl | Clonidine Hcl | 54 | 13 |
| Farxiga | Dapagliflozin Propanediol | 54 | suppressed |
| Sucralfate | Sucralfate | 53 | 16 |
| Januvia | Sitagliptin Phosphate | 52 | 12 |
| Breo Ellipta | Fluticasone/Vilanterol | 49 | suppressed |
| Mupirocin | Mupirocin | 49 | 35 |
| Levetiracetam | Levetiracetam | 48 | suppressed |
| Benazepril Hcl | Benazepril Hcl | 47 | 11 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 46 | suppressed |
| Aripiprazole | Aripiprazole | 45 | 11 |
| Quetiapine Fumarate | Quetiapine Fumarate | 45 | 11 |
| Colchicine | Colchicine | 44 | 15 |
| Raloxifene Hcl | Raloxifene Hcl | 44 | suppressed |
| Xigduo Xr | Dapaglifloz Propaned/Metformin | 44 | suppressed |
| Cephalexin | Cephalexin | 43 | 25 |
| Doxazosin Mesylate | Doxazosin Mesylate | 43 | 11 |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 43 | 11 |
| Nystatin | Nystatin | 43 | 18 |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 43 | 11 |
| Amitriptyline Hcl | Amitriptyline Hcl | 41 | suppressed |
| Finasteride | Finasteride | 41 | 13 |
| Ibandronate Sodium | Ibandronate Sodium | 41 | 11 |
| Synthroid | Levothyroxine Sodium | 40 | suppressed |
| Dexlansoprazole Dr | Dexlansoprazole | 39 | suppressed |
| Lactulose | Lactulose | 39 | 20 |
| Sumatriptan Succinate | Sumatriptan Succinate | 39 | 14 |
| Propranolol Hcl Er | Propranolol Hcl | 38 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 37 | 31 |
| Desvenlafaxine Succinate Er | Desvenlafaxine Succinate | 37 | suppressed |
| Fluconazole | Fluconazole | 37 | 20 |
| Nebivolol Hcl | Nebivolol Hcl | 37 | suppressed |
| Primidone | Primidone | 37 | suppressed |
| Ropinirole Hcl | Ropinirole Hcl | 37 | suppressed |
| Janumet Xr | Sitagliptin Phos/Metformin Hcl | 36 | suppressed |
| Acyclovir | Acyclovir | 35 | 13 |
| Diphenoxylate-Atropine | Diphenoxylate Hcl/Atropine | 35 | 18 |
| Testosterone Cypionate | Testosterone Cypionate | 35 | suppressed |
| Breztri Aerosphere | Budesonide/Glycopyr/Formoterol | 34 | suppressed |
| Buspirone Hcl | Buspirone Hcl | 33 | 15 |
| Alendronate Sodium | Alendronate Sodium | 32 | suppressed |
| Fluoxetine Hcl | Fluoxetine Hcl | 32 | suppressed |
| Topiramate | Topiramate | 30 | suppressed |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 29 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 29 | suppressed |
| Glipizide | Glipizide | 29 | suppressed |
| Lacosamide | Lacosamide | 29 | suppressed |
| Memantine Hcl | Memantine Hcl | 29 | 11 |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 29 | suppressed |
| Glipizide Er | Glipizide | 28 | suppressed |
| Oxycodone Hcl | Oxycodone Hcl | 28 | suppressed |
| Stiolto Respimat | Tiotropium Br/Olodaterol Hcl | 28 | suppressed |
| Temazepam | Temazepam | 28 | suppressed |
| Felodipine Er | Felodipine | 27 | suppressed |
| Ipratropium Bromide | Ipratropium Bromide | 27 | suppressed |
| Tradjenta | Linagliptin | 27 | suppressed |
| Vitamin D2 | Ergocalciferol (Vitamin D2) | 27 | suppressed |
| Amoxicillin | Amoxicillin | 26 | 25 |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 26 | 14 |
| Mirtazapine | Mirtazapine | 26 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 26 | suppressed |
| Paxlovid | Nirmatrelvir/Ritonavir | 26 | 26 |
| Dicyclomine Hcl | Dicyclomine Hcl | 25 | suppressed |
| Humalog | Insulin Lispro | 25 | suppressed |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 25 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 23 | 17 |
| Pentoxifylline | Pentoxifylline | 23 | suppressed |
| Diclofenac Sodium | Diclofenac Sodium | 22 | suppressed |
| Lansoprazole | Lansoprazole | 22 | suppressed |
| Premarin | Estrogens, Conjugated | 22 | suppressed |
| Zolpidem Tartrate Er | Zolpidem Tartrate | 22 | suppressed |
| Dextroamphetamine-Amphet Er | Dextroamphetamine/Amphetamine | 21 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 21 | suppressed |
| Methocarbamol | Methocarbamol | 21 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 21 | suppressed |
| Anoro Ellipta | Umeclidinium Brm/Vilanterol Tr | 20 | suppressed |
| Wixela Inhub | Fluticasone Propion/Salmeterol | 20 | suppressed |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 19 | suppressed |
| Nano 2nd Gen Pen Needle | Pen Needle, Diabetic | 19 | suppressed |
| Fenofibrate | Fenofibrate | 18 | suppressed |
| Megestrol Acetate | Megestrol Acetate | 18 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 18 | suppressed |
| Symbicort | Budesonide/Formoterol Fumarate | 18 | suppressed |
| Enalapril Maleate | Enalapril Maleate | 17 | suppressed |
| Levofloxacin | Levofloxacin | 17 | 13 |
| Metoclopramide Hcl | Metoclopramide Hcl | 17 | suppressed |
| Phenytoin Sodium Extended | Phenytoin Sodium Extended | 17 | suppressed |
| Vyvanse | Lisdexamfetamine Dimesylate | 17 | suppressed |
| Benazepril-Hydrochlorothiazide | Benazepril/Hydrochlorothiazide | 16 | suppressed |
| Hydralazine Hcl | Hydralazine Hcl | 16 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 16 | suppressed |
| Prochlorperazine Maleate | Prochlorperazine Maleate | 16 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 16 | suppressed |
| Terazosin Hcl | Terazosin Hcl | 16 | suppressed |
| Tobramycin | Tobramycin | 16 | 12 |
| Estradiol (Once Weekly) | Estradiol | 15 | suppressed |
| Naproxen | Naproxen | 15 | suppressed |
| Risperidone | Risperidone | 15 | suppressed |
| Ketoconazole | Ketoconazole | 14 | suppressed |
| Metronidazole | Metronidazole | 14 | 13 |
| Minoxidil | Minoxidil | 14 | suppressed |
| Sulfasalazine | Sulfasalazine | 14 | suppressed |
| Synjardy | Empagliflozin/Metformin Hcl | 14 | suppressed |
| Torsemide | Torsemide | 14 | suppressed |
| Tresiba Flextouch U-100 | Insulin Degludec | 14 | suppressed |
| Dupixent Syringe | Dupilumab | 13 | suppressed |
| Glimepiride | Glimepiride | 13 | suppressed |
| Haloperidol | Haloperidol | 13 | suppressed |
| Medroxyprogesterone Acetate | Medroxyprogesterone Acetate | 13 | suppressed |
| Movantik | Naloxegol Oxalate | 13 | suppressed |
| Betamethasone Dipropionate | Betamethasone Dipropionate | 12 | suppressed |
| Clobetasol Propionate | Clobetasol Propionate | 12 | suppressed |
| Dropsafe Prep Pads | Alcohol Antiseptic Pads | 12 | suppressed |
| Gemfibrozil | Gemfibrozil | 12 | suppressed |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 12 | suppressed |
| Midodrine Hcl | Midodrine Hcl | 12 | suppressed |
| Rybelsus | Semaglutide | 12 | suppressed |
| Spironolactone-Hctz | Spironolact/Hydrochlorothiazid | 12 | suppressed |
| Valsartan | Valsartan | 12 | suppressed |
| Verapamil Er | Verapamil Hcl | 12 | suppressed |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 11 | suppressed |
| Dexamethasone | Dexamethasone | 11 | suppressed |
| Itraconazole | Itraconazole | 11 | suppressed |
| Liothyronine Sodium | Liothyronine Sodium | 11 | suppressed |
| Mometasone Furoate | Mometasone Furoate | 11 | suppressed |
| Olanzapine | Olanzapine | 11 | suppressed |
| Prempro | Estrogen,con/M-Progest Acet | 11 | suppressed |
| Probenecid | Probenecid | 11 | suppressed |
| Terbinafine Hcl | Terbinafine Hcl | 11 | suppressed |
| Zaleplon | Zaleplon | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $81.33 · 4 records | Abbott Laboratories | FREESTYLE LIBRE 3, QULIPTA, UBRELVY, WELLBUTRIN | 2 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- How do you evaluate evidence when you have a financial relationship with ABBVIE INC.?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error